Using direct anticoagulants (DOACs) in cancer and other high-risk populations
The major practical advantage of the direct oral anticoagulants (DOACs), comprising the thrombin inhibitor dabigatran and the factor Xa inhibitors apixaban, edoxaban, and rivaroxaban, over vitamin K antagonists is their fixed dosing without the need for laboratory monitoring. With the recent, rap...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Carol Davila University of Medicine and Pharmacy Publishing House
2016-12-01
|
| Series: | Romanian Journal of Military Medicine |
| Online Access: | http://revistamedicinamilitara.ro/wp-content/uploads/2017/01/RJMM-vol-CXIX-nr-3-din-2016.20-25.pdf |